{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:49:55Z","timestamp":1754599795016},"reference-count":83,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,23]]},"DOI":"10.7759\/cureus.62953","type":"journal-article","created":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T12:20:12Z","timestamp":1719145212000},"source":"Crossref","is-referenced-by-count":2,"title":["The Interplay Between Cardiovascular Disease and Lung Cancer"],"prefix":"10.7759","author":[{"given":"Luka","family":"Katic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Diaz Saravia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Nagourney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Torelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Glavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakshi","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elina","family":"Tsyvkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcac016","article-title":"Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019","volume":"9","author":"Raisi-Estabragh Z","year":"2022","unstructured":"Raisi-Estabragh Z, Kobo O, Freeman P, et al.. Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019. Eur Heart J Qual Care Clin Outcomes. 2022, 9:54-63. 10.1093\/ehjqcco\/qcac016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.001","article-title":"New ACC Global Heart\u00a0Attack Treatment Initiative: improving STEMI care worldwide","volume":"75","author":"Levenson B","year":"2020","unstructured":"Levenson B, Herrera C, Wilson BH. New ACC Global Heart\u00a0Attack Treatment Initiative: improving STEMI care worldwide. J Am Coll Cardiol. 2020, 75:1605-8. 10.1016\/j.jacc.2020.03.001","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1539","article-title":"Cancer and heart disease: associations and relations","volume":"21","author":"de Boer RA","year":"2019","unstructured":"de Boer RA, Meijers WC, van der Meer P, van Veldhuisen DJ. Cancer and heart disease: associations and relations. Eur J Heart Fail. 2019, 21:1515-25. 10.1002\/ejhf.1539","journal-title":"Eur J Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.9777","article-title":"American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects","volume":"25","author":"Carver JR","year":"2007","unstructured":"Carver JR, Shapiro CL, Ng A, et al.. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007, 25:3991-4008. 10.1200\/JCO.2007.10.9777","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1201\/9781420006438","article-title":"Pathology of the Heart and Sudden Death in Forensic Medicine","author":"Fineschi V","year":"2006","unstructured":"Fineschi V, Baroldi G, Silver MD. Pathology of the Heart and Sudden Death in Forensic Medicine. CRC Press, Boca Raton, FL; 2006. 10.1201\/9781420006438"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/971453","article-title":"Emerging risk biomarkers in cardiovascular diseases and disorders","volume":"2015","author":"Upadhyay RK","year":"2015","unstructured":"Upadhyay RK. Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids. 2015, 2015:971453. 10.1155\/2015\/971453","journal-title":"J Lipids"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28350","article-title":"A review on coronary artery disease, its risk factors, and therapeutics","volume":"234","author":"Malakar AK","year":"2019","unstructured":"Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019, 234:16812-23. 10.1002\/jcp.28350","journal-title":"J Cell Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000025242.79963.4c","article-title":"B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study","volume":"106","author":"McCullough PA","year":"2002","unstructured":"McCullough PA, Nowak RM, McCord J, et al.. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002, 106:416-22. 10.1161\/01.cir.0000025242.79963.4c","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1058","article-title":"What have we learned about heart failure with mid-range ejection fraction one year after its introduction?","volume":"19","author":"Nauta JF","year":"2017","unstructured":"Nauta JF, Hummel YM, van Melle JP, van der Meer P, Lam CS, Ponikowski P, Voors AA. What have we learned about heart failure with mid-range ejection fraction one year after its introduction?. Eur J Heart Fail. 2017, 19:1569-73. 10.1002\/ejhf.1058","journal-title":"Eur J Heart Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug BA","year":"2010","unstructured":"Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010, 3:588-95. 10.1161\/CIRCHEARTFAILURE.109.930701","journal-title":"Circ Heart Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(01)01788-0","article-title":"ACC\/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)","volume":"39","author":"Eagle KA","year":"2002","unstructured":"Eagle KA, Berger PB, Calkins H, et al.. ACC\/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002, 39:542-53. 10.1016\/s0735-1097(01)01788-0","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2015.12.024","article-title":"Arrhythmia recognition and classification using combined linear and nonlinear features of ECG signals","volume":"127","author":"Elhaj FA","year":"2016","unstructured":"Elhaj FA, Salim N, Harris AR, Swee TT, Ahmed T. Arrhythmia recognition and classification using combined linear and nonlinear features of ECG signals. Comput Methods Programs Biomed. 2016, 127:52-63. 10.1016\/j.cmpb.2015.12.024","journal-title":"Comput Methods Programs Biomed"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(83)90003-0","article-title":"Pathophysiologic mechanisms of cardiac arrhythmias","volume":"106","author":"Wit AL","year":"1983","unstructured":"Wit AL, Rosen MR. Pathophysiologic mechanisms of cardiac arrhythmias. Am Heart J. 1983, 106:798-811. 10.1016\/0002-8703(83)90003-0","journal-title":"Am Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.211","article-title":"Antiarrhythmic therapy in 2014: contemporary approaches to treating arrhythmias","volume":"12","author":"Zipes DP","year":"2015","unstructured":"Zipes DP. Antiarrhythmic therapy in 2014: contemporary approaches to treating arrhythmias. Nat Rev Cardiol. 2015, 12:68-9. 10.1038\/nrcardio.2014.211","journal-title":"Nat Rev Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa241","article-title":"Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153\u2009152 middle-aged individuals","volume":"117","author":"Joseph PG","year":"2021","unstructured":"Joseph PG, Healey JS, Raina P, et al.. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153\u2009152 middle-aged individuals. Cardiovasc Res. 2021, 117:1523-31. 10.1093\/cvr\/cvaa241","journal-title":"Cardiovasc Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2005.10.004","article-title":"Pediatric dysrhythmias","volume":"53","author":"Doniger SJ","year":"2006","unstructured":"Doniger SJ, Sharieff GQ. Pediatric dysrhythmias. Pediatr Clin North Am. 2006, 53:85-105. 10.1016\/j.pcl.2005.10.004","journal-title":"Pediatr Clin North Am"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2018:15:2","article-title":"Sudden cardiac death and arrhythmias","volume":"7","author":"Srinivasan NT","year":"2018","unstructured":"Srinivasan NT, Schilling RJ. Sudden cardiac death and arrhythmias. Arrhythm Electrophysiol Rev. 2018, 7:111-7. 10.15420\/aer.2018:15:2","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047293","article-title":"COVID-19, arrhythmic risk, and inflammation: mind the gap!","volume":"142","author":"Lazzerini PE","year":"2020","unstructured":"Lazzerini PE, Boutjdir M, Capecchi PL. COVID-19, arrhythmic risk, and inflammation: mind the gap!. Circulation. 2020, 142:7-9. 10.1161\/CIRCULATIONAHA.120.047293","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)80037-h","article-title":"Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology","volume":"26","author":"Zipes DP","year":"1995","unstructured":"Zipes DP, DiMarco JP, Gillette PC, et al.. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol. 1995, 26:555-73. 10.1016\/0735-1097(95)80037-h","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0706","article-title":"Valvular heart disease: diagnosis and management","volume":"85","author":"Maganti K","year":"2010","unstructured":"Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010, 85:483-500. 10.4065\/mcp.2009.0706","journal-title":"Mayo Clin Proc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707033370107","article-title":"Valvular heart disease","volume":"337","author":"Carabello BA","year":"1997","unstructured":"Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med. 1997, 337:32-41. 10.1056\/NEJM199707033370107","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71180-5","article-title":"Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin","volume":"16","author":"Oser MG","year":"2015","unstructured":"Oser MG, Niederst MJ, Sequist LV, Engelman JA. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 2015, 16:e165-72. 10.1016\/S1470-2045(14)71180-5","journal-title":"Lancet Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002529","article-title":"Global burden and trends of lung cancer incidence and mortality","volume":"136","author":"Li C","year":"2023","unstructured":"Li C, Lei S, Ding L, et al.. Global burden and trends of lung cancer incidence and mortality. Chin Med J (Engl). 2023, 136:1583-90. 10.1097\/CM9.0000000000002529","journal-title":"Chin Med J (Engl)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: epidemiology, etiology, and prevention","volume":"41","author":"Bade BC","year":"2020","unstructured":"Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020, 41:1-24. 10.1016\/j.ccm.2019.10.001","journal-title":"Clin Chest Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2183","article-title":"Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF","volume":"8","author":"Zhuang X","year":"2019","unstructured":"Zhuang X, Zhao C, Li J, et al.. Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF. Cancer Med. 2019, 8:2858-66. 10.1002\/cam4.2183","journal-title":"Cancer Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S125070","article-title":"Review of checkpoint immunotherapy for the management of non-small cell lung cancer","volume":"7","author":"Raju S","year":"2018","unstructured":"Raju S, Joseph R, Sehgal S. Review of checkpoint immunotherapy for the management of non-small cell lung cancer. Immunotargets Ther. 2018, 7:63-75. 10.2147\/ITT.S125070","journal-title":"Immunotargets Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2022.08.003","article-title":"Inflammation-based different association between anatomical severity of coronary artery disease and lung cancer","volume":"19","author":"Zhao YW","year":"2022","unstructured":"Zhao YW, Yan KX, Sun MZ, Wang YH, Chen YD, Hu SY. Inflammation-based different association between anatomical severity of coronary artery disease and lung cancer. J Geriatr Cardiol. 2022, 19:575-82. 10.11909\/j.issn.1671-5411.2022.08.003","journal-title":"J Geriatr Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.36660\/abc.20200478","article-title":"Association between the severity of coronary artery disease and lung cancer: a pilot cross-sectional study","volume":"118","author":"Sun M","year":"2022","unstructured":"Sun M, Yang Q, Li M, Jing J, Zhou H, Chen Y, Hu S. Association between the severity of coronary artery disease and lung cancer: a pilot cross-sectional study. Arq Bras Cardiol. 2022, 118:478-85. 10.36660\/abc.20200478","journal-title":"Arq Bras Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.5577","article-title":"Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer","volume":"198","author":"Jacobs PC","year":"2012","unstructured":"Jacobs PC, Gondrie MJ, van der Graaf Y, de Koning HJ, Isgum I, van Ginneken B, Mali WP. Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. AJR Am J Roentgenol. 2012, 198:505-11. 10.2214\/AJR.10.5577","journal-title":"AJR Am J Roentgenol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-016-1355-z","article-title":"Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution","volume":"47","author":"Kanzaki R","year":"2017","unstructured":"Kanzaki R, Inoue M, Minami M, Shintani Y, Funaki S, Kawamura T, Okumura M. Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution. Surg Today. 2017, 47:27-34. 10.1007\/s00595-016-1355-z","journal-title":"Surg Today"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivu218","article-title":"Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy?","volume":"19","author":"Tourmousoglou CE","year":"2014","unstructured":"Tourmousoglou CE, Apostolakis E, Dougenis D. Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy?. Interact Cardiovasc Thorac Surg. 2014, 19:673-81. 10.1093\/icvts\/ivu218","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1407211","article-title":"Smoking and mortality--beyond established causes","volume":"372","author":"Carter BD","year":"2015","unstructured":"Carter BD, Abnet CC, Feskanich D, et al.. Smoking and mortality--beyond established causes. N Engl J Med. 2015, 372:631-40. 10.1056\/NEJMsa1407211","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.36660\/abc.20190201","article-title":"Chemotherapy-related anatomical coronary-artery disease in lung cancer patients evaluated by coronary-angiography SYNTAX score","volume":"114","author":"Yang Q","year":"2020","unstructured":"Yang Q, Chen Y, Gao H, et al.. Chemotherapy-related anatomical coronary-artery disease in lung cancer patients evaluated by coronary-angiography SYNTAX score. Arq Bras Cardiol. 2020, 114:1004-12. 10.36660\/abc.20190201","journal-title":"Arq Bras Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq042","article-title":"Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer","volume":"21","author":"Hardy D","year":"2010","unstructured":"Hardy D, Liu CC, Cormier JN, Xia R, Du XL. Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer. Ann Oncol. 2010, 21:1825-33. 10.1093\/annonc\/mdq042","journal-title":"Ann Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.871542","article-title":"Case report: multiple causes of cardiac death after the first infusion of atezolizumab: histopathological and immunohistochemical findings","volume":"13","author":"Kushnareva E","year":"2022","unstructured":"Kushnareva E, Stepanova M, Artemeva E, et al.. Case report: multiple causes of cardiac death after the first infusion of atezolizumab: histopathological and immunohistochemical findings. Front Immunol. 2022, 13:871542. 10.3389\/fimmu.2022.871542","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.02.003","article-title":"Cardiac adverse events in EGFR-mutated non-small cell lung cancer treated with osimertinib","volume":"2","author":"Kunimasa K","year":"2020","unstructured":"Kunimasa K, Kamada R, Oka T, et al.. Cardiac adverse events in EGFR-mutated non-small cell lung cancer treated with osimertinib. JACC CardioOncol. 2020, 2:1-10. 10.1016\/j.jaccao.2020.02.003","journal-title":"JACC CardioOncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051268","article-title":"Cardiovascular complications of systemic therapy in non-small-cell lung cancer","volume":"9","author":"Zaborowska-Szmit M","year":"2020","unstructured":"Zaborowska-Szmit M, Krzakowski M, Kowalski DM, Szmit S. Cardiovascular complications of systemic therapy in non-small-cell lung cancer. J Clin Med. 2020, 9:42-4. 10.3390\/jcm9051268","journal-title":"J Clin Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/s1010-7940(96)01097-4","article-title":"The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis","volume":"11","author":"Yano T","year":"1997","unstructured":"Yano T, Yokoyama H, Fukuyama Y, Takai E, Mizutani K, Ichinose Y. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg. 1997, 11:445-9. 10.1016\/s1010-7940(96)01097-4","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.35460","article-title":"Radiation-induced heart disease: a review of classification, mechanism and prevention","volume":"15","author":"Wang H","year":"2019","unstructured":"Wang H, Wei J, Zheng Q, Meng L, Xin Y, Yin X, Jiang X. Radiation-induced heart disease: a review of classification, mechanism and prevention. Int J Biol Sci. 2019, 15:2128-38. 10.7150\/ijbs.35460","journal-title":"Int J Biol Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.03.104","article-title":"Effective cardiac radiotherapy relieved life-threatening heart failure caused by advanced small cell lung cancer with cardiac metastasis: a case report","volume":"10","author":"Chen CF","year":"2018","unstructured":"Chen CF, Lin MH, Chu KA, Liu WS, Hsiao SH, Lai RS. Effective cardiac radiotherapy relieved life-threatening heart failure caused by advanced small cell lung cancer with cardiac metastasis: a case report. J Thorac Dis. 2018, 10:E250-4. 10.21037\/jtd.2018.03.104","journal-title":"J Thorac Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-129","article-title":"Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report","volume":"6","author":"Voortman J","year":"2006","unstructured":"Voortman J, Giaccone G. Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. BMC Cancer. 2006, 6:129. 10.1186\/1471-2407-6-129","journal-title":"BMC Cancer"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-014-3191-0","article-title":"Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability, agreement and variability","volume":"24","author":"van Hamersvelt RW","year":"2014","unstructured":"van Hamersvelt RW, Willemink MJ, Takx RA, et al.. Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability, agreement and variability. Eur Radiol. 2014, 24:1557-64. 10.1007\/s00330-014-3191-0","journal-title":"Eur Radiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-015-0664-4","article-title":"Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population","volume":"31","author":"Willemink MJ","year":"2015","unstructured":"Willemink MJ, Takx RA, I\u0161gum I, et al.. Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population. Int J Cardiovasc Imaging. 2015, 31:1243-9. 10.1007\/s10554-015-0664-4","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.934369","article-title":"Role of real-world data in assessing cardiac toxicity after lung cancer radiotherapy","volume":"12","author":"Abravan A","year":"2022","unstructured":"Abravan A, Price G, Banfill K, et al.. Role of real-world data in assessing cardiac toxicity after lung cancer radiotherapy. Front Oncol. 2022, 12:934369. 10.3389\/fonc.2022.934369","journal-title":"Front Oncol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e3182431c23","article-title":"Radiation-induced heart disease","volume":"20","author":"Filopei J","year":"2012","unstructured":"Filopei J, Frishman W. Radiation-induced heart disease. Cardiol Rev. 2012, 20:184-8. 10.1097\/CRD.0b013e3182431c23","journal-title":"Cardiol Rev"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-007-0979-8","article-title":"Rheumatic mitral valve stenosis mimicking advanced lung cancer","volume":"22","author":"von Lueder T","year":"2007","unstructured":"von Lueder T, Steine K, Nerdrum T, Steen T, Bay D, Humerfelt S, Atar D. Rheumatic mitral valve stenosis mimicking advanced lung cancer. Heart Vessels. 2007, 22:345-8. 10.1007\/s00380-007-0979-8","journal-title":"Heart Vessels"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308765","article-title":"Radiation-induced valvular heart disease","volume":"102","author":"Gujral DM","year":"2016","unstructured":"Gujral DM, Lloyd G, Bhattacharyya S. Radiation-induced valvular heart disease. Heart. 2016, 102:269-76. 10.1136\/heartjnl-2015-308765","journal-title":"Heart"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.005443","article-title":"Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies","volume":"10","author":"Buza V","year":"2017","unstructured":"Buza V, Rajagopalan B, Curtis AB. Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies. Circ Arrhythm Electrophysiol. 2017, 10:24-6. 10.1161\/CIRCEP.117.005443","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000986","article-title":"Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association","volume":"144","author":"Fradley MG","year":"2021","unstructured":"Fradley MG, Beckie TM, Brown SA, et al.. Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association. Circulation. 2021, 144:e41-55. 10.1161\/CIR.0000000000000986","journal-title":"Circulation"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.07.079","article-title":"Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week","volume":"74","author":"Ball S","year":"2019","unstructured":"Ball S, Ghosh RK, Wongsaengsak S, et al.. Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week. J Am Coll Cardiol. 2019, 74:1714-27. 10.1016\/j.jacc.2019.07.079","journal-title":"J Am Coll Cardiol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245723","article-title":"Cardiac arrhythmias in patients treated for lung cancer: a review","volume":"15","author":"Hawryszko M","year":"2023","unstructured":"Hawryszko M, S\u0142awi\u0144ski G, Tomasik B, Lewicka E. Cardiac arrhythmias in patients treated for lung cancer: a review. Cancers (Basel). 2023, 15:75-7. 10.3390\/cancers15245723","journal-title":"Cancers (Basel)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.03.005","article-title":"Atrial fibrillation and cancer - an unexplored field in cardiovascular oncology","volume":"35","author":"Chu G","year":"2019","unstructured":"Chu G, Versteeg HH, Verschoor AJ, et al.. Atrial fibrillation and cancer - an unexplored field in cardiovascular oncology. Blood Rev. 2019, 35:59-67. 10.1016\/j.blre.2019.03.005","journal-title":"Blood Rev"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001626","article-title":"Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: the PRESAGE Trial","volume":"264","author":"Cardinale D","year":"2016","unstructured":"Cardinale D, Sandri MT, Colombo A, et al.. Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: the PRESAGE Trial. Ann Surg. 2016, 264:244-51. 10.1097\/SLA.0000000000001626","journal-title":"Ann Surg"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euy268","article-title":"Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study","volume":"21","author":"Christensen AM","year":"2019","unstructured":"Christensen AM, Bjerre J, Schou M, et al.. Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study. Europace. 2019, 21:465-74. 10.1093\/europace\/euy268","journal-title":"Europace"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivab140","article-title":"Prognostic significance of preoperative haemoglobin A1c level in patients with lung adenocarcinoma","volume":"33","author":"Ogawa H","year":"2021","unstructured":"Ogawa H, Fujibayashi Y, Nishikubo M, Nishioka Y, Tane S, Kitamura Y, Nishio W. Prognostic significance of preoperative haemoglobin A1c level in patients with lung adenocarcinoma. Interact Cardiovasc Thorac Surg. 2021, 33:534-40. 10.1093\/icvts\/ivab140","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-22-493","article-title":"A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab","volume":"11","author":"Shen Y","year":"2022","unstructured":"Shen Y, Li J, Qiang H, et al.. A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab. Transl Lung Cancer Res. 2022, 11:1619-30. 10.21037\/tlcr-22-493","journal-title":"Transl Lung Cancer Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2014.289","article-title":"Association of serum hemoglobin A1c, C-peptide and insulin-like growth factor-1 levels with the occurrence and development of lung cancer","volume":"2","author":"Zhang M","year":"2014","unstructured":"Zhang M, Li X, Zhang X, Yang Y, Feng Z, Liu X. Association of serum hemoglobin A1c, C-peptide and insulin-like growth factor-1 levels with the occurrence and development of lung cancer. Mol Clin Oncol. 2014, 2:506-8. 10.3892\/mco.2014.289","journal-title":"Mol Clin Oncol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14174","article-title":"Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non-small cell lung cancer patients treated with radiotherapy","volume":"12","author":"Kong M","year":"2021","unstructured":"Kong M, Lim YJ. Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non-small cell lung cancer patients treated with radiotherapy. Thorac Cancer. 2021, 12:3032-8. 10.1111\/1759-7714.14174","journal-title":"Thorac Cancer"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu124","article-title":"Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis","volume":"180","author":"Zhang ZJ","year":"2014","unstructured":"Zhang ZJ, Bi Y, Li S, Zhang Q, Zhao G, Guo Y, Song Q. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis. Am J Epidemiol. 2014, 180:11-4. 10.1093\/aje\/kwu124","journal-title":"Am J Epidemiol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.99","article-title":"Cancer: diabetes therapy and lung cancer","volume":"8","author":"Ozerlat I","year":"2012","unstructured":"Ozerlat I. Cancer: diabetes therapy and lung cancer. Nat Rev Endocrinol. 2012, 8:445. 10.1038\/nrendo.2012.99","journal-title":"Nat Rev Endocrinol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201407-1395OC","article-title":"Survival of patients with stage IV lung cancer with diabetes treated with metformin","volume":"191","author":"Lin JJ","year":"2015","unstructured":"Lin JJ, Gallagher EJ, Sigel K, et al.. Survival of patients with stage IV lung cancer with diabetes treated with metformin. Am J Respir Crit Care Med. 2015, 191:448-54. 10.1164\/rccm.201407-1395OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1177\/1534735419869491","article-title":"Metformin prolongs survival in type 2 diabetes lung cancer patients with EGFR-TKIs","volume":"18","author":"Hung MS","year":"2019","unstructured":"Hung MS, Chuang MC, Chen YC, et al.. Metformin prolongs survival in type 2 diabetes lung cancer patients with EGFR-TKIs. Integr Cancer Ther. 2019, 18:1534735419869491. 10.1177\/1534735419869491","journal-title":"Integr Cancer Ther"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0245-2","article-title":"Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer","volume":"5","author":"Godwin JL","year":"2017","unstructured":"Godwin JL, Jaggi S, Sirisena I, Sharda P, Rao AD, Mehra R, Veloski C. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer. J Immunother Cancer. 2017, 5:40. 10.1186\/s40425-017-0245-2","journal-title":"J Immunother Cancer"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1177\/10781552211004698","article-title":"A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy","volume":"27","author":"McGee K","year":"2021","unstructured":"McGee K, Stone NJ, Wadhwani S, Kanwar YS, Villaflor V, Akhter N. A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy. J Oncol Pharm Pract. 2021, 27:2010-3. 10.1177\/10781552211004698","journal-title":"J Oncol Pharm Pract"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55060-7","article-title":"Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells","volume":"9","author":"Cervantes-Madrid D","year":"2019","unstructured":"Cervantes-Madrid D, Szydzik J, Lind DE, et al.. Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells. Sci Rep. 2019, 9:19353. 10.1038\/s41598-019-55060-7","journal-title":"Sci Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.04.034","article-title":"Identification of ALK in thinness","volume":"181","author":"Orthofer M","year":"2020","unstructured":"Orthofer M, Valsesia A, M\u00e4gi R, et al.. Identification of ALK in thinness. Cell. 2020, 181:1246-62. 10.1016\/j.cell.2020.04.034","journal-title":"Cell"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200476119","article-title":"A hypothalamic pathway for Augmentor \u03b1-controlled body weight regulation","volume":"119","author":"Ahmed M","year":"2022","unstructured":"Ahmed M, Kaur N, Cheng Q, et al.. A hypothalamic pathway for Augmentor \u03b1-controlled body weight regulation. Proc Natl Acad Sci U S A. 2022, 119:e2200476119. 10.1073\/pnas.2200476119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101490","article-title":"Multifaceted roles of ALK family receptors and augmentor ligands in health and disease: a comprehensive review","volume":"13","author":"Katic L","year":"2023","unstructured":"Katic L, Priscan A. Multifaceted roles of ALK family receptors and augmentor ligands in health and disease: a comprehensive review. Biomolecules. 2023, 13:4-6. 10.3390\/biom13101490","journal-title":"Biomolecules"},{"key":"ref70","article-title":"Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo","volume":"52","author":"Vitols S","year":"1992","unstructured":"Vitols S, Peterson C, Larsson O, Holm P, Aberg B. Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. Cancer Res. 1992, 52:6244-7.","journal-title":"Cancer Res"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1159\/000196195","article-title":"Decreases in serum cholesterol levels in advanced lung cancer","volume":"60","author":"Umeki S","year":"1993","unstructured":"Umeki S. Decreases in serum cholesterol levels in advanced lung cancer. Respiration. 1993, 60:178-81. 10.1159\/000196195","journal-title":"Respiration"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215246","article-title":"Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism","volume":"14","author":"Zab\u0142ocka-S\u0142owi\u0144ska K","year":"2019","unstructured":"Zab\u0142ocka-S\u0142owi\u0144ska K, P\u0142aczkowska S, Sk\u00f3rska K, et al.. Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism. PLoS One. 2019, 14:e0215246. 10.1371\/journal.pone.0215246","journal-title":"PLoS One"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6107.210","article-title":"Thyroid function in lung cancer","volume":"1","author":"Ratcliffe JG","year":"1978","unstructured":"Ratcliffe JG, Stack BH, Burt RW, Radcliffe WA, Spilg WG, Cuthbert J, Kennedy RS. Thyroid function in lung cancer. Br Med J. 1978, 1:210-2. 10.1136\/bmj.1.6107.210","journal-title":"Br Med J"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl287","article-title":"Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis","volume":"17","author":"Berghmans T","year":"2006","unstructured":"Berghmans T, Paesmans M, Mascaux C, et al.. Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis. Ann Oncol. 2006, 17:1673-6. 10.1093\/annonc\/mdl287","journal-title":"Ann Oncol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/bs.vh.2017.05.007","article-title":"Roles of thyroid transcription factor 1 in lung cancer biology","volume":"106","author":"Phelps CA","year":"2018","unstructured":"Phelps CA, Lai SC, Mu D. Roles of thyroid transcription factor 1 in lung cancer biology. Vitam Horm. 2018, 106:517-44. 10.1016\/bs.vh.2017.05.007","journal-title":"Vitam Horm"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2011.02.03","article-title":"Lung cancer, thyroid cancer or both: An unusual case presentation","volume":"3","author":"Albany C","year":"2011","unstructured":"Albany C, Jain A, Ulbright TM, Einhorn LH. Lung cancer, thyroid cancer or both: An unusual case presentation. J Thorac Dis. 2011, 3:271-3. 10.3978\/j.issn.2072-1439.2011.02.03","journal-title":"J Thorac Dis"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw640","article-title":"Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer","volume":"28","author":"Osorio JC","year":"2017","unstructured":"Osorio JC, Ni A, Chaft JE, et al.. Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer. Ann Oncol. 2017, 28:583-9. 10.1093\/annonc\/mdw640","journal-title":"Ann Oncol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200204000-00017","article-title":"Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men","volume":"20","author":"Lee SY","year":"2002","unstructured":"Lee SY, Kim MT, Jee SH, Im JS. Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men. J Hypertens. 2002, 20:617-22. 10.1097\/00004872-200204000-00017","journal-title":"J Hypertens"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200204000-00003","article-title":"Hypertension and the risk of cancer: is there new evidence?","volume":"20","author":"Stumpe KO","year":"2002","unstructured":"Stumpe KO. Hypertension and the risk of cancer: is there new evidence?. J Hypertens. 2002, 20:565-7. 10.1097\/00004872-200204000-00003","journal-title":"J Hypertens"},{"key":"ref80","article-title":"Hypertension and risk of brain metastasis from small cell lung cancer: a retrospective follow-up study","volume":"24","author":"Sahmoun AE","year":"2004","unstructured":"Sahmoun AE, Case LD, Chavour S, Kareem S, Schwartz GG. Hypertension and risk of brain metastasis from small cell lung cancer: a retrospective follow-up study. Anticancer Res. 2004, 24:3115-20.","journal-title":"Anticancer Res"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000745076.39504.af","article-title":"Characteristics of healthy vascular ageing (HVA) and early vascular ageing (EVA) in general population. EH-UH Study (Croatian Scientific Foundation)","volume":"39","author":"Glavic MM","year":"2021","unstructured":"Glavic MM, Blagus L, Bosnjak V, et al.. Characteristics of healthy vascular ageing (HVA) and early vascular ageing (EVA) in general population. EH-UH Study (Croatian Scientific Foundation). J Hypertens. 2021, 39:32-4. 10.1097\/01.hjh.0000745076.39504.af","journal-title":"J Hypertens"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000746336.69196.25","article-title":"Estimated pulse wave velocity (EPWV) and mortality in subjects with healthy vascular ageing (HVA) and early vascular ageing (EVA) in general population. EH-UH Study","volume":"39","author":"Blagus L","year":"2021","unstructured":"Blagus L, Bosnjak V, Frkanec S, et al.. Estimated pulse wave velocity (EPWV) and mortality in subjects with healthy vascular ageing (HVA) and early vascular ageing (EVA) in general population. EH-UH Study. J Hypertens. 2021, 39:63-5. 10.1097\/01.hjh.0000746336.69196.25","journal-title":"J Hypertens"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2019.1691528","article-title":"Aortic wall stiffness as a side-effect of anti-cancer medication","volume":"17","author":"Solomou E","year":"2019","unstructured":"Solomou E, Aznaouridis K, Masoura C, Cutajar I, Toutouzas K, Vlachopoulos C, Tousoulis D. Aortic wall stiffness as a side-effect of anti-cancer medication. Expert Rev Cardiovasc Ther. 2019, 17:791-9. 10.1080\/14779072.2019.1691528","journal-title":"Expert Rev Cardiovasc Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259640-the-interplay-between-cardiovascular-disease-and-lung-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T12:20:22Z","timestamp":1719145222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259640-the-interplay-between-cardiovascular-disease-and-lung-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,23]]},"references-count":83,"URL":"https:\/\/doi.org\/10.7759\/cureus.62953","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,23]]}}}